Acute intoxication with many of the antiepileptic drugs may present with mental symptoms (encephalopathy, confusion, psychosis), sometimes in the absence of other clinical signs such as nystagmus, dysarthria or ataxia etc. (Logan and Freeman 1969 ; McDonal and Bolman 1975 ; Ahmad et al. 1975 ; Reynolds 1982) . Atypical anticonvulsant toxicity in mentally retarded children have been reported but not in a specific association with mental retardation (Logan and Freeman 1969 ; Dahl 1967 ; Hoaken et al. 1963 ; Prensky et al. 1971) . In this paper, we present two patients with chronic organic brain syndrome or borderline mental retardation who developed a functional psychosis associated with anticonvulsant toxcity.
Casel
Mr B.C, a 11 year old child with borderline mental retardation, had psychomoter seizures since age of 6 years for which he was given carbamazepine 400 mg / day. Mr BC was admitted in Paediatric ward after he accidently took an overdose. He had slurred speech and bizarre behaviour. All medications were stopped and there was minimal improvement over next one week. An EEG revealed moderate slow wave activity without evidence of an epileptic focus. It was thought that whatever toxic reaction there was, had subsided, so Mr BC was transferred to psychiatry ward for control of his 'hysterical psychosis' (as diagnosed by Pediatrician for not being able to find an organic basis for the symptoms). The carbamazepine was increased to 600 mg/day. Over the next several days, the psychoses worsened and the bizarre motor behaviour increased which included compulsive cleaning, forceful rubbing of his eyes, and choreoathetoid writhing of his hands and body . In addition, his affect became labile. He developed loosening of association, delusions of persecution and self reference and auditory hallucinations in the presence of intact orientation and memory. Complete physical and neurological examination showed minimal instability on the Romberg exmination, with writhing movements as described above. Two days later, his orientation and short term memory were also disturbed. The possibility of toxic psychosis was made (however, blood levels of drug were not determined), so dosage of carbamazepine was decreased. Mr BC's psychosis cleared within five days. He was admitted because of frequent spells of choreoathetoid movements of the extremities, falling and crawling on the floor, bizarre stereotyped movements and autistic thinking, with intact memory and orientation. CT scan and EEG were normal. The neurological examination showed minimal instability on the Romberg .examination with bizarre stereotyped movements. The blood level of phenytoin was 15/ng/ml (normal 10-12/^ig/ml). The patient was given haloperidol 20mg/day, without improvement. The patient's phenytoin dosage was decreased to 100 mg twice daily (blood level 10/xg/ml). The psychosis cleared up within five days. Before coming to psychiatry OPD, Mr ML was taking anticonvulsants (phenytoin) erratically in the past and at times in excessive quantities.
Discussion
Landolt (1958) described a subgroup of patients with usually short-lived episodes of psychosis, which seemed to appear (alternate) at times of good control of seizures, sometimes but not always, associated with 'forced normalization' of the EEG. Some workers have reported less well recognized subacute deterioration in mental function (Subacute encephalopathy, dementia, pseudodegenerative disorder) without more classical signs of toxicity, which is associated with phenytoin and barbiturates (Reynolds 1970; Trimble and Reynolds 1976) . These patients mild chronic organic brain syndrome or mild mental retardation appeared to make them more sensitive to the toxic effects of anticonvulsants and to an atypical presentation i.e., the appearance of functional illness (Franks and Richter 1979) . These two patients appeared schizophrenic at first, with symptoms of thought disorder, inappropriate affect, bizarre behaviour and choreoathetoid movements in a clear sensorium. These atypical presentations did not occur in response to a specific anticonvulsant but rather were found with phenytoin, carbamazepine, primidone and clonazepam (Franks and Richter 1979) . The neurological toxicity induced by anticonvulsants have been reported with normal blood levels (Brooker and Darcey 1973) as was seen in Case 2. In some patients, even the conventional doses of anticonvulsants may produce toxic blood levels (Logan and Freeman 1969) .
One could possibly explain these psychotic episodes as a coincidental functional psychosis in association with anticonvulsant toxicity. This seems unlike, however, given the dramatic improvement in the psychosis when the dosage of anticonvulsant medication was lowered (also reported by Reynolds 1970) . Raising the anticonvulsant dosage would answer the question, but obvious ethical issues prevented this. We hope that these findings will help in evaluating those patients who are being treated for both a seizure disorder and schizophrenia. Some of these patients may simply be suffering from anticonvulsant toxicity rather than the functional illness. Cautiously reducing the medication could lead, as in the above cases, to dramatic improvement. 
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